Media Releases

Maddocks advises global pharma company on acquisition of Southern Cross Pharma

• 05 August 2021 • 2 min read

Maddocks has advised Mumbai-headquartered listed pharmaceutical company Lupin Limited and its wholly-owned subsidiary Generic Health on the acquisition of Southern Cross Pharma, a Melbourne firm engaged in developing, registering, and distributing generic pharmaceuticals products.

The strategic acquisition sees Generic Health gain access to Southern Cross Pharma’s portfolio of more than 60 currently registered products developed over the past 20 years.

Maddocks worked in close collaboration with Lupin legal’s in-house team in Mumbai. Lupin was also advised on the transaction by Deloitte on financial and taxation matters. Southern Cross Pharma was advised by Rankin Business Lawyers and by Morrows Pty Ltd.

The Maddocks Corporate team advising on the acquisition was led by partner Damien Wurzel and senior associate Steven Tang and assisted by associate Jack Coventry and lawyer Cassandra Charlaftis. The Corporate team was supported by partner Lindy Richardson and senior associate Christopher Charalambous from the firm’s Employment, Safety & People team.

About Maddocks

Maddocks is a proudly independent Australian law firm that works closely with corporations, businesses and governments throughout Australia and internationally. We advise national and international clients across the education, government, healthcare, infrastructure and technology sectors, from our Canberra, Melbourne and Sydney offices. Our specialist expertise includes dispute resolution and litigation, employment and safety, financial services, franchising and insolvency.

For more information:

Jason Silverii
Communications Manager
Tel: 03 9258 3509
Mobile: 0407 618 058
jason.silverii@maddocks.com.au

  • Share

Related articles

Online Access